BCBS – Basic Benefit and Medical Policy: Drug Testing in Pain Management and Substance Use Disorder Treatment

Established:
80305, 80306, 80307, G0480, G0481, G0482 G0483, G0659

Experimental:
80320-80377, 83992

Policy guidelines:

One presumptive and one definitive test code may be billed per date of service.

Billing guidelines of definitive drug testing:

These guidelines are effective Oct. 1, 2019.

Bill G0480 through G0483 and G0659 as appropriate, for the number of drug classes tested.

Bill 80XXX and 83992 to report the appropriate drug or metabolite testing. The codes are no longer individually reimbursed for the purpose of this policy; however, we request that they are reported with the appropriate G code.

Contracted laboratories:

Providers should select contracted laboratories for the processing of drug tests. Referring a member to a nonparticipating laboratory may result in unnecessary services (such as processing tests not originally ordered) and greater financial liability for the member. The referring provider may be held accountable for any inappropriate behavior on the part of the nonparticipating laboratory.

This policy is effective on March 1, 2020.

Source: https://www.bcbsm.com/content/dam/microsites/corpcomm/provider/the_record/2020/mar/Record_0320d.shtml